Figure 1From: Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal modelWestern blot analysis. Western blot analysis of the HPV16 E7 produced in E. coli in reducing (lane 1) and non-reducing conditions (lane 2). Molecular mass markers are indicated on the left and the E7 isoforms are indicated on the right.Back to article page